Frequently Asked Questions

CAR-T is a cellular therapy approach based on preparing the patient's own T cells in the laboratory to recognize specific target cells and returning them to the patient.

No. Eligibility is determined by evaluating together the diagnosis, disease subtype, previous treatments, current clinical status, organ functions and other medical factors.

Medical documents are reviewed. If necessary, additional documents or tests may be requested. For patients found suitable, the next evaluation and coordination steps are shared.

The total process varies from patient to patient. It consists of eligibility evaluation, cell collection, cell preparation, pre-treatment planning, infusion and close monitoring stages. The exact schedule is determined after the patient-specific evaluation is completed.

The need for a companion may be evaluated according to the patient's clinical condition, city/country of residence and the treatment team's recommendation. A support plan is especially important during the close follow-up period after treatment.

Yes, evaluation can be started based on medical documents. However, current treatments should only be changed or stopped on the recommendation of the physician following you.

In cases of fever, shortness of breath, chest pain, fainting, altered consciousness, neurological findings, uncontrolled bleeding or rapid deterioration in general condition, emergency health services should be consulted.

No. The application is only the first step for your medical documents to be reviewed by the specialist team for eligibility.

Our team will contact you within one working day using the contact information you provided. If additional documents are needed, they will be requested.

A current epicrisis or physician summary, pathology reports, recent blood tests, imaging reports and a list of previous treatments will help speed up the evaluation.

We respond within one working day in your own language. Our coordination team provides service in 16 languages.